| Authors: |
Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA friedmac@mskcc.org.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Spencer C; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Panageas KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Ribas A; Department of Medicine, University of California Los Angeles, Los Angeles, California, USA., Tawbi H; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tsai K; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Postow M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Shoushtari A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Chapman P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Gherardini P; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Hollmann TJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Chen RO; Personalis Inc, Menlo Park, California, USA., Callahan M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Wolchok J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA. |
